Services
Services
Services
Services
Submit Your Samples to BloodScan for Cutting-Edge CTC Analysis
BloodScan offers advanced circulating tumor cell (CTC) analysis services for academic researchers, biopharma, and cancer centers. By accessing our centralized labs, you can accelerate cancer research, drug development, and translational studies with biopsy-quality CTCs.
BloodScan offers advanced circulating tumor cell (CTC) analysis services for academic researchers, biopharma, and cancer centers. By accessing our centralized labs, you can accelerate cancer research, drug development, and translational studies with biopsy-quality CTCs.
Our Services
Our Services
CTC Enumeration
Track cell counts for prognostic insights and treatment monitoring.
Single-Cell Gene Expression
Transcriptome-level profiling for heterogeneity and drug targets.
EMT/MET Phenotyping
Identify epithelial-to-mesenchymal transitions, linked to metastasis and drug resistance.
Mutation & CNV Analysis
Identify driver mutations and copy number changes in CTCs.
Cancer Stem Cell Marker Detection
Detect CD44, ALDH1, and other markers for self-renewal and therapeutic resistance.
FISH Analysis
Detect rearrangements, fusions, or amplifications (e.g., ALK, ROS1, RET).
CTC Cluster Detection
Quantify clusters associated with aggressive disease.
Protein Expression Profiling
Correlate protein expression with disease stage, EMT, and therapy response.
CTC Enumeration
Track cell counts for prognostic insights and treatment monitoring.
Cancer Stem Cell Marker Detection
Detect CD44, ALDH1, and other markers for self-renewal and therapeutic resistance.
Single-Cell Gene Expression
Transcriptome-level profiling for heterogeneity and drug targets.
FISH Analysis
Detect rearrangements, fusions, or amplifications (e.g., ALK, ROS1, RET).
EMT/MET Phenotyping
Identify epithelial-to-mesenchymal transitions, linked to metastasis and drug resistance.
CTC Cluster Detection
Quantify clusters associated with aggressive disease.
Mutation & CNV Analysis
Identify driver mutations and copy number changes in CTCs.
Protein Expression Profiling
Correlate protein expression with disease stage, EMT, and therapy response.
EMT/MET Phenotyping
Identify epithelial-to-mesenchymal transitions, linked to metastasis and drug resistance.
CTC Enumeration
Track cell counts for prognostic insights and treatment monitoring.
Cancer Stem Cell Marker Detection
Detect CD44, ALDH1, and other markers for self-renewal and therapeutic resistance.
FISH Analysis
Detect rearrangements, fusions, or amplifications (e.g., ALK, ROS1, RET).
CTC Cluster Detection
Quantify clusters associated with aggressive disease.
Single-Cell Gene Expression
Transcriptome-level profiling for heterogeneity and drug targets.
Protein Expression Profiling
Correlate protein expression with disease stage, EMT, and therapy response.
Mutation & CNV Analysis
Identify driver mutations and copy number changes in CTCs.
CTC Enumeration
Track cell counts for prognostic insights and treatment monitoring.
Cancer Stem Cell Marker Detection
Detect CD44, ALDH1, and other markers for self-renewal and therapeutic resistance.
Single-Cell Gene Expression
Transcriptome-level profiling for heterogeneity and drug targets.
FISH Analysis
Detect rearrangements, fusions, or amplifications (e.g., ALK, ROS1, RET).
EMT/MET Phenotyping
Identify epithelial-to-mesenchymal transitions, linked to metastasis and drug resistance.
CTC Cluster Detection
Quantify clusters associated with aggressive disease.
Mutation & CNV Analysis
Identify driver mutations and copy number changes in CTCs.
Protein Expression Profiling
Correlate protein expression with disease stage, EMT, and therapy response.
Why Work With BloodScan?
Why Work With BloodScan?
Access to live, viable CTCs equivalent to biopsy samples
Access to live, viable CTCs equivalent to biopsy samples
Proven platform with >97% genomic concordance to tissue biopsy
Proven platform with >97% genomic concordance to tissue biopsy
Collaborations with leading cancer centers and biopharma partners
Collaborations with leading cancer centers and biopharma partners
Dual-lab infrastructure for Asia and US-based research projects
Dual-lab infrastructure for Asia and US-based research projects
Where We Operate
Where We Operate
We currently provide CTC analysis through two centralized laboratories:
National Biotechnology Research Park (Taiwan)
University of Michigan (United States)
Researchers can submit blood samples to either site, depending on location and preference.
We currently provide CTC analysis through two centralized laboratories:
National Biotechnology Research Park (Taiwan)
University of Michigan (United States)
Researchers can submit blood samples to either site, depending on location and preference.
To learn more about our research services or request a customized quote, please contact us directly.
To learn more about our research services or request a customized quote, please contact us directly.